Neuropace
Price & Volume
Stats
See more52W Range | $5.45-$18.97 |
Market Cap | $337.4M |
Shares Short | 944,906 |
Financials
See moreRevenue (12 Mos) | $88.5M |
Revenue Growth (YoY) | 22.1% |
Gross Profit (12 Mos) | $67M |
Diluted EPS | -$0.82 |
News
See moreYahoo Finance • 2 months ago
NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth
Yahoo Finance • 2 months ago
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
Yahoo Finance • 3 months ago
NeuroPace's SWOT analysis: innovative epilepsy treatment stock faces growth hurdles
Yahoo Finance • 3 months ago
NeuroPace stock rating reiterated at Overweight by Cantor Fitzgerald
About
CEO | Mr. Joel D. Becker |
Address | 455 North Bernardo Avenue, Mountain View, CA, United States, 94043 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 209 |
